Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • War Day 115: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin
    War Day 115: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
  • Mvix Launches a Device-Agnostic, Visual Communication Platform for Hybrid Workforce and Remote Audience
    Mvix Launches a Device-Agnostic, Visual Communication Platform for Hybrid Workforce and Remote Audience Business
  • CEO of the WCAa Chad Newton to Receive LAHC Excellence and Great Achievements Award Annual Awards Gala
    CEO of the WCAa Chad Newton to Receive LAHC Excellence and Great Achievements Award Annual Awards Gala Aviation
  • Wallis Bank Opens Second San Antonio Branch, Expanding Services in Area
    Wallis Bank Opens Second San Antonio Branch, Expanding Services in Area Business
  • Los Angeles Trial Lawyers’ Charities’ 3-on-3 Basketball Tournament Scores Big & Raises ,000 for Great Tryke Giveaway
    Los Angeles Trial Lawyers’ Charities’ 3-on-3 Basketball Tournament Scores Big & Raises $87,000 for Great Tryke Giveaway Business
  • Launch of the Vision for Adapted Crops and Soils (VACS) with a Keynote Address from Special Envoy Fowler and Introduction by Ambassador McCain
    Launch of the Vision for Adapted Crops and Soils (VACS) with a Keynote Address from Special Envoy Fowler and Introduction by Ambassador McCain World News
  • Concierge Auctions Announces Lineup for September Hong Kong Live Auction at The Upper House
    Concierge Auctions Announces Lineup for September Hong Kong Live Auction at The Upper House World News
  • Marine Gensets Market Size, Share, Revenue, Trends, and Drivers For 2024-2033
    Marine Gensets Market Size, Share, Revenue, Trends, and Drivers For 2024-2033 World News
GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China

GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China

Posted on March 20, 2023 By NewsEditor
GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in ChinaGB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in ChinaAccording to Statista, China has the second largest pharmaceutical market in the world and plant-based medicines are very well accepted, which makes China a potential target market for Gb Sciences.

GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China
Patent


LAS VEGAS, March 20, 2023 (Newswire.com) - Gb Sciences, Inc. (OTCQB:GBLX), a leading cannabis- and plant-inspired biopharmaceutical research and development company, has recently been issued a patent in China to protect its proprietary cannabinoid-containing formulation for the treatment of Parkinson's disease. China is an increasingly important pharmaceutical market with cultural acceptance of plant-based formulations, which is a good fit for Gb Sciences' drug candidates. Gb Sciences' first international patent also confirms that the Company's intellectual property strategy can work globally and strengthens the Company's patent portfolio. The global market for treatments of Parkinson's disease is projected to grow to $8.8 billion by the year 2026, and new therapies to address Parkinson's disease symptoms are greatly needed.

"The issuance of Gb Sciences' first international patent protecting methods of using our proprietary cannabinoid-containing formulations for treating Parkinson's disease is an important milestone in the development of these vitally important therapies. Gb Sciences' recent patent issued in China validates both our plant-inspired drug discovery process and intellectual property strategy, which involve defining and protecting Minimum Essential Mixtures," explained Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences, Inc. "Gb Sciences starts its drug discovery process with plant-based therapies that are working anecdotally or in traditional medical systems, then we systematically reduce the number of compounds to reveal Minimum Essential Mixtures. Gb Sciences' novel Minimum Essential Mixtures retain the increased efficacy of whole plant medicines, but they are easier to manufacture with precision at scale like single ingredient drugs. These Minimum Essential Mixtures are a viable alternative to standard single ingredient drugs or traditional whole plant medicines."

Gb Sciences' Minimum Essential Mixture-based drug development strategy does not aim to treat complex diseases as if they were caused by a single factor, but instead addresses the combination of factors that lead to a complex human disorder. Minimum Essential Mixtures (MEMs) are potentially more effective than single ingredient drugs because the different active ingredients target the multiple human processes responsible for complex diseases, such as neurodegeneration, heart disease, and cancers. As such, MEMs may offer a more holistic treatment for complex disorders such as Parkinson's disease that cannot be attributed to a single cause, while maintaining the manufacturing and quality control advantages of single ingredient drugs.

Gb Sciences' patent portfolio currently contains six issued U.S. and four issued foreign patents, as well as 15 U.S. and 49 foreign patent-pending applications that cover our novel AI-enabled drug discovery platform and proprietary plant-inspired therapies for more than 65 different disorders. 

To learn more about Gb Sciences, visit www.gbsciences.com.

About Gb Sciences and GbS Global Biopharma

Gb Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company creating patented, disease-targeted formulations of cannabis- and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The 'plant-inspired' active ingredients in its therapeutic mixtures are synthetic homologues identical to the original plant compounds but produced under current Good Manufacturing Practices. Gb Sciences' intellectual property portfolio contains six issued U.S. and four issued foreign patents, as well as 15 U.S. and 49 foreign patent-pending applications. In its drug development pipeline, Gb Sciences has five preclinical phase product development programs. Gb Sciences' lead program for Parkinson's disease is being prepared for a first-in-human clinical trial. Gb Sciences' formulations for chronic pain, anxiety and depression are currently in preclinical animal studies with researchers at the National Research Council of Canada (NRC). The company also received positive preclinical proof-of-concept data supporting its complex mixtures for the treatment of Cytokine Release Syndrome, and its lead candidates will be optimized based on late-stage preclinical studies at Michigan State University. Gb Sciences' productive research and development network includes distinguished universities, hospitals, and Contract Research Organizations. To learn more, visit www.gbsciences.com.

Forward-Looking Statements

This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects," "intends," "plans," "may," "could," "should," "anticipates," "likely," "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Contact Information:
Alexis Quintal
[email protected]


Original Source: GB Sciences' First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson's Disease Has Been Issued in China

The post GB Sciences’ First International Patent Protecting Its Proprietary Cannabinoid-Based Formulations for Parkinson’s Disease Has Been Issued in China first appeared on Social Gov.

Business

Post navigation

Previous Post: War Day 220: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin
Next Post: War Day 219: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin

Related Posts

  • UK Based Leading Mobility Specialist Now Running Dubai Clinic For Wheelchair Users
    UK Based Leading Mobility Specialist Now Running Dubai Clinic For Wheelchair Users Business
  • OMEGA Announces Expansion of Groundbreaking, Non-Invasive Temperature Sensor Technology, Now Available for Use on Plastic Pipes
    OMEGA Announces Expansion of Groundbreaking, Non-Invasive Temperature Sensor Technology, Now Available for Use on Plastic Pipes Business
  • Sunshine Care to Open Newest Clinic Nov. 1, 2022, Using Mostly ReStore Store/Habitat for Humanity Materials
    Sunshine Care to Open Newest Clinic Nov. 1, 2022, Using Mostly ReStore Store/Habitat for Humanity Materials Business
  • Atlanta-Based Digital Marketing Company Interactive Search Marketing Has Announced Their Rebranding to Grater Digital
    Atlanta-Based Digital Marketing Company Interactive Search Marketing Has Announced Their Rebranding to Grater Digital Business
  • ActivePro Rehab Partners Announces Expansion With Acquisition of Rehab Excellence Center
    ActivePro Rehab Partners Announces Expansion With Acquisition of Rehab Excellence Center Business
  • ATI Adds Kress Restoration to its Portfolio of Companies
    ATI Adds Kress Restoration to its Portfolio of Companies Business
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« Aug    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Arizona Marketing Agency AVLC Launches AI-Powered Services to Help Small Businesses Compete with Industry GiantsSeptember 5, 2025
  • Warriors HeArt Gallery Gives a Voice to Warrior Recovery Stories at Grunt Style HQ San Antonio with Public Art DisplaySeptember 4, 2025
  • Quasi Robotics Unveils Model C2 MiniSeptember 4, 2025
  • Rockbell Software Sdn Bhd Announces E-Invoicing Readiness for LHDN MyInvoisSeptember 4, 2025
  • Aircraft Refurbishing Market Trends, Industry Size and Forecast, 2031 | Sabreliner Aviation, Safran S.A.September 3, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • VaynerSports Signs Global Esports Icon and Creator Clix
    VaynerSports Signs Global Esports Icon and Creator Clix Business
  • The Secure Messaging In Healthcare Market to Grow Beyond Linear Progression at a CAGR of 20%
    The Secure Messaging In Healthcare Market to Grow Beyond Linear Progression at a CAGR of 20% World News
  • Ukraine claims hundreds of Russian soldiers killed by missile attack – BBC News
    Ukraine claims hundreds of Russian soldiers killed by missile attack – BBC News World News
  • Secretary Alejandro Mayorkas Discusses Evolving Homeland Security Challenges at 59th Munich Security Conference
    Secretary Alejandro Mayorkas Discusses Evolving Homeland Security Challenges at 59th Munich Security Conference World News
  • Get The Child Tax Credit With No Income in 2023 and 2024 Announced by Harbor Financial
    Get The Child Tax Credit With No Income in 2023 and 2024 Announced by Harbor Financial Business
  • On-Screen Tours that Ignite Digital Growth for Local Businesses
    On-Screen Tours that Ignite Digital Growth for Local Businesses Business
  • APEX DEMANDS US GOVERNMENT PASSENGER COMPENSATION FOR AIR TRAFFIC FAILURES
    APEX DEMANDS US GOVERNMENT PASSENGER COMPENSATION FOR AIR TRAFFIC FAILURES World News
  • Carla A. Murphy of the United States Celebrated As New Author During Public Book Launch In Hampton VA
    Carla A. Murphy of the United States Celebrated As New Author During Public Book Launch In Hampton VA World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .